KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Idexx Laboratories (IDXX) EPS (Weighted Average and Diluted): 2009-2025

Historic EPS (Weighted Average and Diluted) for Idexx Laboratories (IDXX) over the last 17 years, with Sep 2025 value amounting to $3.40.

  • Idexx Laboratories' EPS (Weighted Average and Diluted) rose 21.43% to $3.40 in Q3 2025 from the same period last year, while for Sep 2025 it was $12.61, marking a year-over-year increase of 21.72%. This contributed to the annual value of $10.67 for FY2024, which is 6.06% up from last year.
  • As of Q3 2025, Idexx Laboratories' EPS (Weighted Average and Diluted) stood at $3.40, which was down 6.34% from $3.63 recorded in Q2 2025.
  • Over the past 5 years, Idexx Laboratories' EPS (Weighted Average and Diluted) peaked at $3.63 during Q2 2025, and registered a low of $1.56 during Q2 2022.
  • Moreover, its 3-year median value for EPS (Weighted Average and Diluted) was $2.67 (2023), whereas its average is $2.79.
  • In the last 5 years, Idexx Laboratories' EPS (Weighted Average and Diluted) skyrocketed by 82.17% in 2021 and then plummeted by 33.33% in 2022.
  • Idexx Laboratories' EPS (Weighted Average and Diluted) (Quarterly) stood at $1.89 in 2021, then rose by 8.99% to $2.06 in 2022, then grew by 12.14% to $2.31 in 2023, then rose by 13.42% to $2.62 in 2024, then grew by 21.43% to $3.40 in 2025.
  • Its EPS (Weighted Average and Diluted) was $3.40 in Q3 2025, compared to $3.63 in Q2 2025 and $2.96 in Q1 2025.